Scientists Meet at Rockefeller to Discuss Molecular Strategies in Biological Evolution

In science, things often aren't as simple as they seem. This is certainly the case for the genetic code. Even as elegant experiments in the 1960s assigned DNA and messenger RNA (mRNA) base triplets to specific amino acids, researchers were wondering if a protein's blueprints were the sole meaning imparted by those long strings of A, T, G and C. But back then, they could do little more than wonder. Today, with more than a dozen genomes sequenced, researchers can ask age-old questions as well as

Written byRicki Lewis
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

In science, things often aren't as simple as they seem. This is certainly the case for the genetic code. Even as elegant experiments in the 1960s assigned DNA and messenger RNA (mRNA) base triplets to specific amino acids, researchers were wondering if a protein's blueprints were the sole meaning imparted by those long strings of A, T, G and C. But back then, they could do little more than wonder.

Today, with more than a dozen genomes sequenced, researchers can ask age-old questions as well as pose new ones about the meanings of DNA sequence organization, and begin to tease answers from data (R. Lewis, The Scientist, 12[1]:11, Jan. 5, 1998). That's why several dozen biochemists, geneticists, molecular biologists, and evolutionary biologists convened at Rockefeller University in New York City, June 27 to 29, for "Molecular Strategies in Biological Evolution," a conference sponsored by the New York Academy of Sciences. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies